InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the detailed record of transactions filed by Khalid Nabilsi. Insider active across 1 company, notably Hikma Pharmaceuticals PLC. Cumulatively, 8 disclosures have been logged. Regulator: RNS (LSE). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Khalid Nabilsi is a declarant with 8 filings in total. In the 8 sampled recent filings, all related to Hikma Pharmaceuticals PLC, the date range runs from 2024-03-13 to 2026-06-05, and the modal transaction nature is Purchase. His listed role at Hikma Pharmaceuticals PLC is Deputy CEO, North America and Europe.